During the premarket session, Sanofi ADS moved 6.03%, compared to 0.27% for the S&P 500.
Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is now trading -18.54% away from its average analyst target price of $63.5 per share. The 4 analysts following the stock have set target prices ranging from $62.0 to $65.0, and on average give Sanofi ADS a rating of strong buy.
Over the last year, SNY shares have gone up 0.39%, which represents a difference of 13.47% when compared to the S&P 500. The stock's 52 week high is $56.08 per share whereas its 52 week low is $36.91. Based on Sanofi ADS's average gross margins growth of 0.55% over the last four years, its core business remains strong and the stock price may maintain this level of performance.
| Date Reported | Revenue (k) | Cost of Revenue (k) | Gross Margin | YoY Growth |
|---|---|---|---|---|
| 2022-12-31 | $45,389,000 | $13,695,000 | 69.83% | 1.62% |
| 2021-12-31 | $39,175,000 | $12,255,000 | 68.72% | 1.85% |
| 2020-12-31 | $37,369,000 | $12,157,000 | 67.47% | -1.04% |
| 2019-12-31 | $37,631,000 | $11,976,000 | 68.18% | 0.34% |
| 2018-12-31 | $35,677,000 | $11,435,000 | 67.95% | n/a |
